Cargando…
Bioengineering coagulation factors for improved hemophilia treatments(): Comment on: the mutation F309S increases FVIII secretion in human cell line
Autores principales: | Hounkpe, Bidossessi Wilfried, de Paula, Erich Vinicius |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Hematologia e Hemoterapia
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4997896/ https://www.ncbi.nlm.nih.gov/pubmed/27521852 http://dx.doi.org/10.1016/j.bjhh.2016.05.001 |
Ejemplares similares
-
Comments on: Frequency of human platelet antigens in oncohematological patients with thrombocytopenia and the probability of incompatibility to platelet transfusions
por: de Paula, Erich Vinicius
Publicado: (2012) -
In Vitro FVIII-Encoding Transgenic Mesenchymal Stem Cells Maintain Successful Coagulation in FVIII-Deficient Plasma Mimicking Hemophilia A
por: Hemşinlioğlu, Cansu, et al.
Publicado: (2023) -
Issues in the measurement of quality of life in
hemophilia
por: Feldman, Brian M.
Publicado: (2013) -
HRT Atlas v1.0 database: redefining human and mouse housekeeping genes and candidate reference transcripts by mining massive RNA-seq datasets
por: Hounkpe, Bidossessi Wilfried, et al.
Publicado: (2020) -
Tissue factor-dependent coagulation activation by heme: A thromboelastometry study
por: de Souza, Gleice Regina, et al.
Publicado: (2017)